Metabolic reprogramming and circadian disruption drive cellular senescence. Discover how repurposing vutiglabridin to target ...

Longevity investment went from $3.8bn in 2023 to $8.5bn in 2024 (albeit in the context of a broader biotech market recovery).

From studying microRNAs in embryonic stem cells to exploring exosomes in anti-tumor immunity, Blelloch illustrates how ...

GC Therapeutics (GCTx), a pioneering biotechnology company advancing the next generation of cell-based medicines through its TFome™ (Transcription-Factor-ome) induced pluripotent stem cell (iPSC) ...

Years before he conducted the research that would earn him a Nobel Prize in Physiology and Medicine, Shinya Yamanaka, MD, Ph.D., was a postdoctoral scientist at Gladstone Institutes, studying genes.

It is well known that students who prepare in advance perform better in exams. Now, it appears that the skin can do the same. Rather than scrambling to repair itself only after injury occurs, a Korean ...

The industrial food matrix is not merely delivering poor nutrition. It is executing a systemic epigenetic intervention on human gene expression, suppressing tumor-suppressor pathways, destabilizing ...

Bryan Johnson spends $2 million a year trying not to die, but the data from places where people actually live the longest keeps pointing to something his protocol can't measure. I've been thinking ...

Can cells be made biologically younger? A new, high profile clinical trial aims to find out. The idea of reversing aging and immortality has long lived in myths and lore, or at the edge of science ...